Background: The purpose of this study was to evaluate the prognostic value of atrial
| INTRODUC TI ON
Atrial fibrillation (AF) occurs in 6%-21% of patients with acute coronary syndrome (ACS).
1-15 AF causes loss of "atrial kick," tachycardia and irregular rhythm because it decreases cardiac output. 16, 17 Therefore, it has been considered that ACS patients with AF have a worse prognosis than patients without AF. Several studies have identified increased mortality attributed to complication of ACS with AF. [1] [2] [3] [4] [5] [7] [8] [9] [11] [12] [13] [14] [15] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] However, there is controversy as to whether AF is an independent predictor. 4, 14, 22, 27 Thus, it is thought that clinical factors other than AF may determine prognosis. In a number of studies, ACS patients with AF tend to be older than those without AF. There are also reports that such patients have a poor outcome after adjustment for patient clinical characteristics. 3, 8, 9, 11, [19] [20] [21] 24 However, the evidence derived from these studies is quite limited.
Percutaneous coronary intervention (PCI) has become the first line treatment in ACS patients. However, while there have been many reports concerning AF in patients with ACS in the thrombolytic era, 1, 3, 5, 6, [18] [19] [20] [21] 23 there still a small number of such reports in the PCI era. 4, 14, 22, 24, 27 Previous reports have suggested that mortality differed in patients with pre-existing AF or new-onset AF. Some reports directly compared each type of AF, 2, 5, 6, 8, [11] [12] [13] [14] [15] 23, 25 and in some of the studies there were indications that new-onset AF worsened the prognosis 2, 5, 8, 11, 12, 14, 15, 23 ; however, others concluded that new-onset AF did not worsen the prognosis. 6, 13, 25 The aim of this study was to evaluate the prognostic value of AF as a complicating factor in patients with ACS, in the current PCI era; comparisons were made among non-AF and all-AF groups, and between non-AF, new-onset AF, and pre-existing AF groups. ischemic cerebral attack (TIA), and congestive heart failure (CHF) requiring hospitalization. Clinical events were investigated from medical records. Time to outcome event was measured in months from the day of admission.
| ME THODS
Patients with AF were divided into two groups: the new-onset and the pre-existing AF groups. New-onset AF was defined as no past history of AF before admission and was observed for the first time during in-hospital stays. Pre-existing AF was defined as previously documented AF before admission, whether paroxysmal or persistent AF. While existence of valvular AF was an exclusion criterion, no such patients were identified during the study period.
Patients were first divided into AF-absent (non-AF) and AF-present (all-AF) groups. Second, study patients were further divided into three groups: non-AF, new-onset AF, and pre-existing AF groups. We compared prognosis among these groups using Cox regression analysis.
| Statistical analysis
Data are presented as the mean ± SD. Comparison of means was performed using unpaired Student's t test and the Mann-Whitney U test. Statistical differences in categorical data were explored using the chi-squared test. Survival rates were assessed using the Kaplan-Meier method. The cox proportional hazards regression analysis was used to identify clinical predictors for outcome events.
Multivariate logistic regression analysis of significant clinical factors was carried out to identify determinants of prognosis. Factors such as CHADS 2 score and emergency PCI or CABG related to multicollinearity were excluded from the analysis. P-values less than 0.05 were considered significant. All analyses were performed using SPSS ver.
21.0 statistical software (Chicago, IL, USA).
| RE SULTS
The mean follow-up period was 1.4 ± 1.2 years and the follow-up rate of this study was 95%. Numbers of non-AF and all-AF patients were 538 and 110, respectively. Numbers of new-onset AF and pre-existing AF patients were 67 and 43, respectively. Patient clinical characteristics are shown in Table 1 , and patients were divided into non-AF and all-AF groups. The all-AF group was older and the prevalence of renal dysfunction, history of CI/TIA, peripheral artery disease (PAD), Killip classification ≥2, LM lesion, and CABG procedures was significantly higher than in the non-AF group. There was no significant difference in in-hospital mortality rates between the two groups. 
TA B L E 2 Baseline clinical characteristics of non-AF, new-onset AF, and pre-existing AF groups

| Comparison among the non-AF, new-onset AF, and pre-existing AF groups
Patient clinical characteristics are shown in Table 2 in which patients were divided into three groups: non-AF, new-onset AF, and pre-existing AF groups. There was no significant difference in age between newonset and pre-existing AF groups. Prevalence of a previous CI/TIA, PAD, and LM lesion was highest in patients with pre-existing AF, but Killip classification ≥2 and CABG procedures were highest in patients with new-onset AF. In addition, LVEF was lowest in the new-onset AF group.
In-hospital mortality rates tended to be higher in the new-onset AF group than in the other groups, but the difference was not significant. CHADS 2 score in the pre-existing AF group was significantly higher than in the new-onset AF group (CHADS 2 score in the preexisting AF group was 3.2 ± 1.5, and CHADS 2 score in the new-onset AF group was 2.6 ± 1.5, P = 0.028, Table 2 ). Distribution of CHADS 2 scores among patients is shown in Figure 1 . Distribution of CHADS 2 scores was significantly higher in the pre-existing AF group than in the new-onset AF group (P = 0.022).
During the follow-up period, 78 all-cause deaths and 42 cardiac deaths were confirmed (Table 3) .
| Long-term prognostic differences when comparing two groups or three groups
In a comparison between the non-AF and all-AF groups, all-AF patients had a worse prognosis than the non-AF patients (Log-Rank: (Figure 2, left) . When patients were divided into three groups, the new-onset AF had a worse prognosis than the other groups (Log-Rank: P = 0.025), as illustrated by the Kaplan-Meier curves shown in Figure 2 , right. However, long-term mortality was not significantly different on the Cox proportional hazards regression analysis adjusted by age, sex, hypertension, hyperlipidemia, diabetes mellitus, current smoking, and renal dysfunction ( Table 4 ). The hazard ratio of congestive heart failure requiring hospitalization was significantly higher in the all-AF and new-onset AF groups than in the non-AF group. However, there was no significant difference in the pre-existing AF group compared to the non-AF group. Prevalence of TA B L E 3 Primary and secondary end points during follow-up period F I G U R E 2 Kaplan-Meier analysis of cumulative survival rates for patients with ACS during follow-up period
TA B L E 4 Cox-regression analysis
Non-AF group vs All-AF group
Non-AF group vs New-onset AF group
Non-AF group vs Pre-existing AF group
Hazard ratio (95% CI) P Hazard ratio (95% CI) P Hazard ratio (95% CI) P hemorrhage, CI/TIA, or recurrent myocardial infarction showed no significant differences among the three groups.
Because there were significant differences in age among these groups, we carried out additional Cox proportional hazards regression analysis in cases ≥75 or <75 years of age. There was no significant difference in long-term mortality between the two groups (Table 5 ). In multivariate logistic regression analysis, AF was not an independent predictor of all-cause death. Significant independent predictors of all-cause death were renal dysfunction, history of PAD, Killip classification ≥2, and LVEF (Table 6 ).
| D ISCUSS I ON
| Comparison between the non-AF and all-AF groups
In our study, incidence of all-cause death was significantly higher in the all-AF group than in the non-AF group by Kaplan-Meier analysis.
However, there was no significant difference between the all-AF and non-AF groups by Cox proportional hazards regression analysis. In multivariate logistic regression analysis, AF was not an independent predictor of all-cause death. Renal dysfunction, history of PAD, Killip classification ≥2, and LVEF remained independent predictors of allcause death. In the past, studies evaluating predictors of all-cause death reported that lower LVEF or Killip classification, or both, was included in the independent predictor of all-cause death. 3, 14, 22, 26, 27 Some reports showed that renal dysfunction was the independent predictor of all-cause death. 14, 27 Renal dysfunction, history of PAD, and Killip classification ≥2 were significantly more prevalent in the all-AF group than in the non-AF group. LVEF tended to be lower in the all-AF group than in the non-AF group. We considered that, in this study, the presence of AF was not an independent predictor for all-cause death, but prevalence of independent predictors was significantly higher in the all-AF group. Therefore, incidence of allcause death was higher in the all-AF group than in the non-AF group.
Previous reports demonstrated that prevalence of chronic kidney disease in patients with AF was significantly higher than in the corresponding non-AF group. 31 This study indicated that advanced age, congestive heart failure, and cardiovascular disease were independent predictors of complications due to AF.
In this study, patients with AF were older and the prevalence of Killip classification ≥2 and renal dysfunction were significantly higher than in patients without AF as previously reported 3, 15, 22, 26 ( Table 7) . It was notable that these reports found all-cause mortality to be higher in patients with AF than in those without.
| Comparison among the non-AF group, the new-onset AF group, and the pre-existing AF group
We analyzed the relevance of time of onset of AF. Previous reports concluded that patients with new-onset AF had a worse prognosis 2, 5, 8, 12, 14, 15, 20, 21, 23, 26, 27 (Table 7) . In this study, Kaplan-Meier analysis demonstrated significant differences for all-cause death in the three groups; in particular, the new-onset AF group showed the poorest outcome. However, in the Cox proportional hazards regression analysis, adjusted for several factors, there were no significant differences in all-cause death among the three groups. Most of the past studies that reported on three or more groups were studied with only Kaplan-Meier analysis 2, [13] [14] [15] 25 (Table 7) . Only three reports were studied with Cox proportional hazards regression analy- (Table 7) . Lau et al 8 reported that incidence of all-cause death was significantly higher in the new-onset AF group than in the non-AF group by Kaplan-Meier analysis. However, on the Cox proportional hazards regression analysis, adjusted for several factors, there were no significant differences in all-cause death between the two groups. Incidence of all-cause death in the pre-existing group was still significantly higher than in the non-AF group after adjustment.
In this study, Killip classification and LVEF were significant predictors of all-cause death, and prevalence of Killip classification ≥2 was significantly higher and LVEF was lowest in the new-onset AF group.
Furthermore, on the Cox proportional hazards regression analysis, prevalence of CHF requiring hospitalization was significantly higher in the new-onset AF group than in the non-AF group. Therefore, we considered that a high prevalence of Killip classification ≥2 and lower LVEF were directly associated with long-term mortality and CHF requiring hospitalization in the new-onset AF group. Strict management during the follow-up period is needed for the ACS patients complicating with new-onset AF.
In this study, we evaluated CHADS 2 scores. Among previous studies, none reported CHADS 2 score for ACS research-related AF. CHADS 2 score and distribution of CHADS 2 scores were significantly higher in the pre-existing AF group than in the new-onset AF group. The incidence of the previous cerebral infarction or TIA was significantly higher in the pre-existing AF group than in the new-onset AF group. The results may be due to the higher CHADS2 score in the pre-existing AF group.
| Study limitations
There were several limitations with this study. First, the number of patients was relatively small, and the study was retrospective in nature. Second, although our definition of AF included persistent and paroxysmal AF, our study did not illustrate these differences. AF type may determine mortality. Finally, the precise period of antiplatelet and anticoagulant drug treatment was unclear because drug prescription during follow-up was carried out at private outpatient clinics in almost all the cases. In this study, the influence of medication was unclear.
| CON CLUS ION
In our study, AF was not an independent predictor of all-cause death in ACS patients, but renal dysfunction, history of PAD, and Killip classification ≥2 were independent predictors. Prevalence of these independent predictors was significantly higher in ACS patients complicated with AF.
In particular, ACS patients complicating with new-onset AF had a higher prevalence of Killip classification ≥2, lower LVEF, and a significant risk for CHF requiring hospitalization during the follow-up. Therefore, ACS patients with new-onset AF may have a worse prognosis.
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